Nermina Ferizovic
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Preferences for Advanced Therapy Medicinal Products: Understanding the Published Literature on the Value of Innovative Health Interventions.
Journal: Inquiry : a journal of medical care organization, provision and financing
Published: November 01, 2025
In response to Gulcin Akinci's and Haluk Topaloglu's letter regarding our article "Predictors of loss of ambulation in Duchenne muscular dystrophy: A systematic review and meta-analysis".
Journal: Journal of neuromuscular diseases
Published: February 27, 2025
Value attributes of advanced therapy medicinal products: a documentary analysis of comments received from stakeholders during reimbursement decisions to England's National Institute of Health and Care Excellence.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: January 16, 2025
Correction: Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis.
Journal: PloS one
Published: December 09, 2024
Predictors of Loss of Ambulation in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis.
Journal: Journal of neuromuscular diseases
Published: April 26, 2024
Timing of Clinical Interventions in Patients With Duchenne Muscular Dystrophy: A Systematic Review and Grading of Evidence.
Journal: Journal of neuromuscular diseases
Published: April 18, 2022
Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal.
Journal: Advances in therapy
Published: November 12, 2019
α5β1 integrin recycling promotes Arp2/3-independent cancer cell invasion via the formin FHOD3.
Journal: The Journal of cell biology
Published: September 16, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026